Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Cognitive-behavioural and social factors do not predict recurrent secondary healthcare use in patients with fibromyalgia: a longitudinal study.

Vervoort VM, Vriezekolk JE, Olde Hartman TC, van Helmond T, van der Laan WH, Geenen R, van den Ende CH.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):44-50. Epub 2018 Nov 29.

2.

Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial.

Flik CE, Laan W, Zuithoff NPA, van Rood YR, Smout AJPM, Weusten BLAM, Whorwell PJ, de Wit NJ.

Lancet Gastroenterol Hepatol. 2019 Jan;4(1):20-31. doi: 10.1016/S2468-1253(18)30310-8. Epub 2018 Nov 23.

PMID:
30473202
3.

Most Important Frequently Asked Questions From Patients With Hip or Knee Osteoarthritis: A Best-Worst Scaling Exercise.

Claassen AAOM, Kremers-van de Hei KCALC, van den Hoogen FHJ, van der Laan WH, Rijnen WHC, Koëter S, Botman J, Busch VJJF, Schers HJ, van den Ende CHM.

Arthritis Care Res (Hoboken). 2019 Jul;71(7):885-892. doi: 10.1002/acr.23719. Epub 2019 May 21.

PMID:
30055092
4.

Preliminary effects of a regional approached multidisciplinary educational program on healthcare utilization in patients with hip or knee osteoarthritis: an observational study.

Claassen AAOM, Schers HJ, Koëter S, van der Laan WH, Kremers-van de Hei KCALC, Botman J, Busch VJJF, Rijnen WHC, van den Ende CHM.

BMC Fam Pract. 2018 Jun 6;19(1):82. doi: 10.1186/s12875-018-0769-7.

5.

Psychopathology, cognition and outcome in Dutch and immigrant first-episode psychosis patients.

Stouten LH, Veling W, Laan W, Van der Gaag M.

Early Interv Psychiatry. 2019 Jun;13(3):646-656. doi: 10.1111/eip.12561. Epub 2018 Mar 30.

PMID:
29603625
6.

Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open-Label Transition From Reference Infliximab to Biosimilar Infliximab.

Tweehuysen L, van den Bemt BJF, van Ingen IL, de Jong AJL, van der Laan WH, van den Hoogen FHJ, den Broeder AA.

Arthritis Rheumatol. 2018 Jan;70(1):60-68. doi: 10.1002/art.40324. Epub 2017 Dec 7.

7.

Development of the "Treatment beliefs in knee and hip OsteoArthritis (TOA)" questionnaire.

Selten EMH, Vriezekolk JE, Schers HJ, Nijhof MW, van der Laan WH, van der Meulen-Dilling RG, Geenen R, van den Ende CHM.

BMC Musculoskelet Disord. 2017 Sep 19;18(1):402. doi: 10.1186/s12891-017-1762-3.

8.

Barriers Impeding the Use of Non-pharmacological, Non-surgical Care in Hip and Knee Osteoarthritis: The Views of General Practitioners, Physical Therapists, and Medical Specialists.

Selten EMH, Vriezekolk JE, Nijhof MW, Schers HJ, van der Meulen-Dilling RG, van der Laan WH, Geenen R, van den Ende CHM.

J Clin Rheumatol. 2017 Dec;23(8):405-410. doi: 10.1097/RHU.0000000000000562.

PMID:
28926466
9.

Enzyme Activity by Design: An Artificial Rhodium Hydroformylase for Linear Aldehydes.

Jarvis AG, Obrecht L, Deuss PJ, Laan W, Gibson EK, Wells PP, Kamer PCJ.

Angew Chem Int Ed Engl. 2017 Oct 23;56(44):13596-13600. doi: 10.1002/anie.201705753. Epub 2017 Sep 13.

10.

Treatment Beliefs Underlying Intended Treatment Choices in Knee and Hip Osteoarthritis.

Selten EMH, Geenen R, Schers HJ, van den Hoogen FHJ, van der Meulen-Dilling RG, van der Laan WH, Nijhof MW, van den Ende CHM, Vriezekolk JE.

Int J Behav Med. 2018 Apr;25(2):198-206. doi: 10.1007/s12529-017-9671-2.

PMID:
28664420
11.

Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome.

Flik CE, Bakker L, Laan W, van Rood YR, Smout AJ, de Wit NJ.

World J Gastroenterol. 2017 Mar 28;23(12):2223-2233. doi: 10.3748/wjg.v23.i12.2223. Review.

12.

Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment?

Pasma A, Schenk C, Timman R, van 't Spijker A, Appels C, van der Laan WH, van den Bemt B, Goekoop R, Hazes JM, Busschbach JJ.

PLoS One. 2017 Feb 2;12(2):e0171070. doi: 10.1371/journal.pone.0171070. eCollection 2017.

13.

Hierarchical structure and importance of patients' reasons for treatment choices in knee and hip osteoarthritis: a concept mapping study.

Selten EM, Geenen R, van der Laan WH, van der Meulen-Dilling RG, Schers HJ, Nijhof MW, van den Ende CH, Vriezekolk JE.

Rheumatology (Oxford). 2017 Feb;56(2):271-278. doi: 10.1093/rheumatology/kew409. Epub 2016 Nov 17.

PMID:
27864564
14.

Psychosocial predictors of DMARD adherence in the first three months of treatment for early arthritis.

Pasma A, Hazes JM, Busschbach JJ, van der Laan WH, Appels C, de Man YA, Nieboer D, Timman R, van 't Spijker A.

Patient Educ Couns. 2017 Jan;100(1):126-132. doi: 10.1016/j.pec.2016.07.019. Epub 2016 Jul 15.

PMID:
27516438
15.

Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.

Bijlsma JWJ, Welsing PMJ, Woodworth TG, Middelink LM, Pethö-Schramm A, Bernasconi C, Borm MEA, Wortel CH, Ter Borg EJ, Jahangier ZN, van der Laan WH, Bruyn GAW, Baudoin P, Wijngaarden S, Vos PAJM, Bos R, Starmans MJF, Griep EN, Griep-Wentink JRM, Allaart CF, Heurkens AHM, Teitsma XM, Tekstra J, Marijnissen ACA, Lafeber FPJ, Jacobs JWG.

Lancet. 2016 Jul 23;388(10042):343-355. doi: 10.1016/S0140-6736(16)30363-4. Epub 2016 Jun 7.

PMID:
27287832
16.

Cost of illness and illness perceptions in patients with fibromyalgia.

Vervoort VM, Vriezekolk JE, Olde Hartman TC, Cats HA, van Helmond T, van der Laan WH, Geenen R, van den Ende CH.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2 Suppl 96):S74-82. Epub 2016 Feb 8.

PMID:
26886404
17.

Reasons for Treatment Choices in Knee and Hip Osteoarthritis: A Qualitative Study.

Selten EM, Vriezekolk JE, Geenen R, van der Laan WH, van der Meulen-Dilling RG, Nijhof MW, Schers HJ, van den Ende CH.

Arthritis Care Res (Hoboken). 2016 Sep;68(9):1260-7. doi: 10.1002/acr.22841. Epub 2016 Jul 28.

18.

Local Geographical Distribution of Acute Involuntary Psychiatric Admissions in Subdistricts In and Around Utrecht, the Netherlands.

Braam AW, van Ommeren OW, van Buuren ML, Laan W, Smeets HM, Engelhard IM.

J Emerg Med. 2016 Mar;50(3):449-57. doi: 10.1016/j.jemermed.2015.06.057. Epub 2015 Dec 21.

19.

Comparison of medical costs generated by IBS patients in primary and secondary care in the Netherlands.

Flik CE, Laan W, Smout AJ, Weusten BL, de Wit NJ.

BMC Gastroenterol. 2015 Nov 26;15:168. doi: 10.1186/s12876-015-0398-8.

20.

Non-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease.

Pasma A, Schenk CV, Timman R, Busschbach JJ, van den Bemt BJ, Molenaar E, van der Laan WH, Schrauwen S, Van't Spijker A, Hazes JM.

Arthritis Res Ther. 2015 Oct 8;17:281. doi: 10.1186/s13075-015-0801-4.

21.

Effects of a culturally sensitive assessment on symptom profiles in native Dutch and Moroccan patients with a first psychosis referral.

Zandi T, Havenaar JM, Laan W, Kahn RS, Brink Wv.

Transcult Psychiatry. 2016 Feb;53(1):45-59. doi: 10.1177/1363461515577288. Epub 2015 Apr 7.

PMID:
25851336
22.

Psychosocial functioning in first-episode psychosis and associations with neurocognition, social cognition, psychotic and affective symptoms.

Stouten LH, Veling W, Laan W, van der Helm M, van der Gaag M.

Early Interv Psychiatry. 2017 Feb;11(1):23-36. doi: 10.1111/eip.12210. Epub 2015 Jan 13.

PMID:
25585960
23.

Differences in health care utilisation between elderly from ethnic minorities and ethnic Dutch elderly.

Verhagen I, Ros WJ, Steunenberg B, Laan W, de Wit NJ.

Int J Equity Health. 2014 Dec 20;13:125. doi: 10.1186/s12939-014-0125-z.

24.

Validity and reliability of the Katz-15 scale to measure unfavorable health outcomes in community-dwelling older people.

Laan W, Zuithoff NP, Drubbel I, Bleijenberg N, Numans ME, de Wit NJ, Schuurmans MJ.

J Nutr Health Aging. 2014 Nov;18(9):848-54. doi: 10.1007/s12603-014-0479-3.

PMID:
25389963
25.

Erratum to: Risk of psychiatric treatment for mood disorders and psychotic disorders among migrants and Dutch nationals in Utrecht, The Netherlands.

Selten JP, Laan W, Kupka R, Smeets HM, van Os J.

Soc Psychiatry Psychiatr Epidemiol. 2015 Jan;50(1):167-9. doi: 10.1007/s00127-014-0964-3. No abstract available.

PMID:
25249329
26.

Psychotic symptoms, cognition and affect as predictors of psychosocial problems and functional change in first-episode psychosis.

Stouten LH, Veling W, Laan W, van der Helm M, van der Gaag M.

Schizophr Res. 2014 Sep;158(1-3):113-9. doi: 10.1016/j.schres.2014.06.023. Epub 2014 Jul 5.

PMID:
25008791
27.

Can assertive community treatment remedy patients dropping out of treatment due to fragmented services?

Drukker M, Laan W, Dreef F, Driessen G, Smeets H, Van Os J.

Community Ment Health J. 2014 May;50(4):454-9. doi: 10.1007/s10597-013-9652-0. Epub 2013 Nov 1.

PMID:
24178633
28.

Factors associated with increasing functional decline in multimorbid independently living older people.

Laan W, Bleijenberg N, Drubbel I, Numans ME, de Wit NJ, Schuurmans MJ.

Maturitas. 2013 Jul;75(3):276-81. doi: 10.1016/j.maturitas.2013.04.005. Epub 2013 May 8.

29.

An incidence study of diagnosed autism-spectrum disorders among immigrants to the Netherlands.

van der Ven E, Termorshuizen F, Laan W, Breetvelt EJ, van Os J, Selten JP.

Acta Psychiatr Scand. 2013 Jul;128(1):54-60. doi: 10.1111/acps.12054. Epub 2012 Dec 9.

PMID:
23216206
30.

Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer.

Guan NC, Termorshuizen F, Laan W, Smeets HM, Zainal NZ, Kahn RS, De Wit NJ, Boks MP.

Soc Psychiatry Psychiatr Epidemiol. 2013 Aug;48(8):1289-95. doi: 10.1007/s00127-012-0612-8. Epub 2012 Oct 27.

PMID:
23104669
31.

[A case study; ethnicity and clozapine, a risky combination?].

Laan WJ, Ramlal D.

Tijdschr Psychiatr. 2012;54(9):829-33. Dutch.

32.

Cognitive deficits and ethnicity: a cohort study of early psychosis patients in The Netherlands.

Stouten LH, Veling W, van der Helm M, Laan W, van der Gaag M.

Soc Psychiatry Psychiatr Epidemiol. 2013 Jan;48(1):37-47. doi: 10.1007/s00127-012-0521-x. Epub 2012 Jun 14.

PMID:
22696073
33.

Progression of joint damage despite control of inflammation in rheumatoid arthritis: a role for cartilage damage driven synovial fibroblast activity.

Lafeber FP, Van der Laan WH.

Ann Rheum Dis. 2012 Jun;71(6):793-5. doi: 10.1136/annrheumdis-2011-200950. No abstract available.

PMID:
22566404
34.

Psychosis and suicide risk by ethnic origin and history of migration in the Netherlands.

Termorshuizen F, Wierdsma AI, Visser E, Drukker M, Sytema S, Laan W, Smeets HM, Selten JP.

Schizophr Res. 2012 Jul;138(2-3):268-73. doi: 10.1016/j.schres.2012.03.035. Epub 2012 Apr 21.

35.

Fast Sparse Level Sets on Graphics Hardware.

Jalba AC, van der Laan WJ, Roerdink JB.

IEEE Trans Vis Comput Graph. 2013 Jan;19(1):30-44. doi: 10.1109/TVCG.2012.69. Epub 2012 Mar 6.

PMID:
22392718
36.

Familial clustering of schizophrenia, bipolar disorder, and major depressive disorder.

Aukes MF, Laan W, Termorshuizen F, Buizer-Voskamp JE, Hennekam EA, Smeets HM, Ophoff RA, Boks MP, Kahn RS.

Genet Med. 2012 Mar;14(3):338-41. doi: 10.1016/gim.2011.16. Epub 2012 Jan 5.

PMID:
22241106
37.

A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study).

Flik CE, van Rood YR, Laan W, Smout AJ, Weusten BL, Whorwell PJ, de Wit NJ.

BMC Gastroenterol. 2011 Dec 20;11:137. doi: 10.1186/1471-230X-11-137.

38.

Predictive validity of a culturally informed diagnosis of schizophrenia: a 30 month follow-up study with first episode psychosis.

Zandi T, Havenaar JM, Laan W, Kahn RS, van den Brink W.

Schizophr Res. 2011 Dec;133(1-3):29-35. doi: 10.1016/j.schres.2011.09.024. Epub 2011 Oct 20.

39.

A comorbid anxiety disorder does not result in an excess risk of death among patients with a depressive disorder.

Laan W, Termorshuizen F, Smeets HM, Boks MP, de Wit NJ, Geerlings MI.

J Affect Disord. 2011 Dec;135(1-3):284-91. doi: 10.1016/j.jad.2011.08.026. Epub 2011 Sep 21.

PMID:
21937123
40.

The psychiatric case register middle Netherlands.

Smeets HM, Laan W, Engelhard IM, Boks MP, Geerlings MI, de Wit NJ.

BMC Psychiatry. 2011 Jun 29;11:106. doi: 10.1186/1471-244X-11-106.

41.

Paternal age and psychiatric disorders: findings from a Dutch population registry.

Buizer-Voskamp JE, Laan W, Staal WG, Hennekam EA, Aukes MF, Termorshuizen F, Kahn RS, Boks MP, Ophoff RA.

Schizophr Res. 2011 Jul;129(2-3):128-32. doi: 10.1016/j.schres.2011.03.021. Epub 2011 Apr 12.

42.

Bioinspired catalyst design and artificial metalloenzymes.

Deuss PJ, den Heeten R, Laan W, Kamer PC.

Chemistry. 2011 Apr 18;17(17):4680-98. doi: 10.1002/chem.201003646. Epub 2011 Mar 23.

PMID:
21480401
43.

Risk of psychiatric treatment for mood disorders and psychotic disorders among migrants and Dutch nationals in Utrecht, The Netherlands.

Selten JP, Laan W, Kupka R, Smeets HM, van Os J.

Soc Psychiatry Psychiatr Epidemiol. 2012 Feb;47(2):271-8. doi: 10.1007/s00127-010-0335-7. Epub 2011 Jan 4. Erratum in: Soc Psychiatry Psychiatr Epidemiol. 2015 Jan;50(1):167-9.

PMID:
21203744
44.

Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis.

van Nimwegen-Campailla L, van Beveren N, Laan W, van den Brink W, Linszen D, de Haan L.

Pharmacopsychiatry. 2010 Nov;43(7):281. doi: 10.1055/s-0030-1263172. Epub 2010 Sep 13. No abstract available.

PMID:
20839158
45.

Incidence of schizophrenia among Moroccan immigrants to the Netherlands.

Selten JP, Laan W, Veen ND, Blom JD, Veling W, Hoek HW.

Schizophr Res. 2010 Dec;124(1-3):240-1. doi: 10.1016/j.schres.2010.08.010. Epub 2010 Sep 1. No abstract available.

PMID:
20813502
46.

Synthesis of hybrid transition-metalloproteins via thiol-selective covalent anchoring of Rh-phosphine and Ru-phenanthroline complexes.

den Heeten R, Muñoz BK, Popa G, Laan W, Kamer PC.

Dalton Trans. 2010 Sep 28;39(36):8477-83. doi: 10.1039/c0dt00239a. Epub 2010 Jul 6.

PMID:
20603670
47.

Highly efficient and site-selective phosphane modification of proteins through hydrazone linkage: development of artificial metalloenzymes.

Deuss PJ, Popa G, Botting CH, Laan W, Kamer PC.

Angew Chem Int Ed Engl. 2010 Jul 19;49(31):5315-7. doi: 10.1002/anie.201002174. No abstract available.

PMID:
20572235
48.

Low treatment adherence with antipsychotics is associated with relapse in psychotic disorders within six months after discharge.

Laan W, van der Does Y, Sezgi B, Smeets HM, Stolker JJ, Wit NJ, Heerdink ER.

Pharmacopsychiatry. 2010 Aug;43(6):221-4. doi: 10.1055/s-0030-1254090. Epub 2010 May 25.

PMID:
20503150
49.

Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial.

Laan W, Grobbee DE, Selten JP, Heijnen CJ, Kahn RS, Burger H.

J Clin Psychiatry. 2010 May;71(5):520-7. doi: 10.4088/JCP.09m05117yel.

PMID:
20492850
50.

Artificial metalloenzymes through cysteine-selective conjugation of phosphines to photoactive yellow protein.

Laan W, Muñoz BK, den Heeten R, Kamer PC.

Chembiochem. 2010 Jun 14;11(9):1236-9. doi: 10.1002/cbic.201000159. No abstract available.

PMID:
20432427

Supplemental Content

Support Center